Company / Gross Profit per Share
Boston Scientific Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$9.27
FY2025
5-year range
$5.40 / $9.27
FY2021-FY2025
Trend
+19.9%
vs FY2024
Sector context
#49 of 99
Health Care
What the data says
At $9.27, Boston Scientific's gross profit per share ranks #49 of 99 in the Health Care sector. Gross Profit per Share has increased for 5 consecutive years, from $5.00 in FY2020 to $9.27 in FY2025.
Based on SEC 10-K filings.
9.27 in FY2025 with a 5-year CAGR of +13.1%.
Improved from $6.90 to $9.27 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +15.2%
- 5-Year CAGR
- +13.1%
- 10-Year CAGR
- -
Sector benchmark
#49 of 99 in Health CareTop 49% of 99This company $9.27 Sector average $13.99
▼
-33.7% below sector average
Key checks
Key Insights
- Boston Scientific's gross profit per share has grown for 5 consecutive years.
- In FY2025, gross profit per share increased 19.9% year-over-year.
- Ranks #49 out of 99 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.27 | +19.9% |
| FY2024 | $7.73 | +12.0% |
| FY2023 | $6.90 | +13.9% |
| FY2022 | $6.06 | +12.2% |
| FY2021 | $5.40 | +8.0% |
| FY2020 | $5.00 | -8.4% |
| FY2019 | $5.46 | +7.9% |
| FY2018 | $5.06 | +7.7% |
| FY2017 | $4.70 | +6.2% |
| FY2016 | $4.43 | +10.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026